
CNO Financial Group, Inc.
NYSE•CNO
CEO: Mr. Gary Chandru Bhojwani
Sector: Financial Services
Industry: Insurance - Life
Listing Date: 2003-09-10
CNO Financial Group, Inc., through its subsidiaries, develops, markets, and administers health insurance, annuity, individual life insurance, insurance products, and financial services for senior and middle-income markets in the United States. It offers Medicare supplement, supplemental health, and long-term care insurance policies; life insurance; and annuities, as well as Medicare advantage plans to individuals through phone, online, mail, and face-to-face. The company also focuses on sale of voluntary benefit life and health insurance products for businesses, associations, and other membership groups by interacting with customers at their place of employment. In addition, it provides fixed indexed annuities; fixed interest annuities, including fixed rate single and flexible premium deferred annuities; single premium immediate annuities; supplemental health products, such as specified disease, accident, and hospital indemnity products; and long-term care plans primarily to retirees and older self-employed individuals in the middle-income market. Further, the company offers universal life and other interest-sensitive life products; and traditional life policies that include whole life, graded benefit life, term life, and single premium whole life products, as well as graded benefit life insurance products. It markets its products under the Bankers Life, Washington National, and Colonial Penn brand names. The company was founded in 1979 and is headquartered in Carmel, Indiana.
Contact Information
Market Cap
$4.09B
P/E (TTM)
14.3
14.1
Dividend Yield
1.6%
52W High
$43.56
52W Low
$34.63
52W Range
Rank33Top 18.8%
5.2
F-Score
Modified Piotroski Analysis
Based on 10-year fundamentals
Average • 5.2 / 9 points
Scoring Range (0-9)
8-9: Excellent Value
6-7: Strong Fundamentals
4-5: Average Quality
0-3: Weak Performance
Data Period: 2015-2024
Financial Dashboard
Q3 2025 Data
Revenue
$1.19B+5.24%
4-Quarter Trend
EPS
$0.00-97.29%
4-Quarter Trend
FCF
$197.80M-14.45%
4-Quarter Trend
2025 Q3 Earnings Highlights
Key Highlights
Strong Q3 Net Income Q3 2025 Net Income reached 23.1M USD, significantly up from 9.3M USD in Q3 2024, showing quarterly profitability strength.
Total Assets Increased Total assets grew to 38.3B USD as of September 30, 2025, up from 37.8B USD at year-end 2024, reflecting asset base expansion.
Major Goodwill Impairment Recognized 96.7M USD total impairment charge for goodwill and intangibles due to valuation indicators identified in the quarter.
Reinsurance Transaction Closed Second Bermuda reinsurance transaction executed, reinsuring 1.8B USD of inforce supplemental health statutory reserves effective October 1, 2025.
Risk Factors
Significant Asset Impairment Recorded 96.7M USD goodwill and intangible asset impairment charge as of September 30, 2025, impacting year-to-date net income results.
Litigation Exposure Remains Various legal actions pending; ultimate outcome uncertain, potentially resulting in material adverse effect on financial condition or cash flows.
Regulatory Oversight Risks Insurance subsidiaries face significant risks from regulatory investigations, potentially leading to fines or adverse impacts on capital and dividend capacity.
Investment Portfolio Volatility Future investment results, including realized losses, may diminish invested asset values and negatively impact profitability, liquidity, and financial condition.
Outlook
Exiting Fee Services Business Intention announced to exit fee services business, expecting 15M USD to 20M USD pre-tax exit charges in Q4 2025.
Narrowed 2025 EPS Guidance Narrowing expected operating EPS guidance range to $3.75 to $3.85, excluding significant items, reflecting strategic focus shift.
Increased ROE Target Increasing run rate operating ROE target to 200 basis points improvement through 2027, incorporating favorable impacts from business exit.
Higher Cash Flow Expected Increasing expected excess cash flow to holding company to $365M to $385M range, reflecting second Bermuda transaction impact.
Peer Comparison
Revenue (TTM)
BHF$7.60B
GNW$7.11B
CNO$4.44B
Gross Margin (Latest Quarter)
CADE100.0%
INTR100.0%
75.8%
Key Metrics
Symbol | Market Cap | P/E (TTM) | ROE (TTM) | Debt to Assets |
|---|---|---|---|---|
| CADE | $7.94B | 15.1 | 9.1% | 4.3% |
| LMND | $5.95B | -29.3 | -36.1% | 7.4% |
| AGO | $4.19B | 11.2 | 7.2% | 0.0% |
Long-Term Trends
Last 4 Quarters
Revenue
Net Income
Operating Cash Flow
4Q Revenue CAGR
2.7%
Moderate Growth
4Q Net Income CAGR
-48.2%
Declining Profitability
Cash Flow Stability
100%
Strong Cash Flow
Research & Insights
Next earnings:Feb 5, 2026
EPS:$1.20
|Revenue:-
Reports
All Years
Form 10-Q - Q3 2025
Period End: Sep 30, 2025|Filed: Nov 6, 2025|Revenue: $1.19B+5.2%|EPS: $0.00-97.3%MissForm 10-Q - Q2 2025
Period End: Jun 30, 2025|Filed: Aug 6, 2025|Revenue: $1.15B+8.0%|EPS: $0.91-15.7%BeatForm 10-Q - Q1 2025
Period End: Mar 31, 2025|Filed: May 7, 2025|Revenue: $1.00B-12.9%|EPS: $0.14-86.4%MissForm 10-K - FY 2024
Period End: Dec 31, 2024|Filed: Feb 26, 2025|Revenue: $4.45B+7.2%|EPS: $3.81+56.1%BeatForm 10-Q - Q3 2024
Period End: Sep 30, 2024|Filed: Nov 7, 2024|Revenue: $1.13B+19.2%|EPS: $0.09-94.0%MissForm 10-Q - Q2 2024
Period End: Jun 30, 2024|Filed: Aug 9, 2024|Revenue: $1.07B+4.3%|EPS: $1.08+68.8%BeatForm 10-Q - Q1 2024
Period End: Mar 31, 2024|Filed: May 6, 2024|Revenue: $1.15B+14.6%|EPS: $1.03-10400.0%BeatForm 10-K - FY 2023
Period End: Dec 31, 2023|Filed: Feb 23, 2024|Revenue: $4.15B+15.9%|EPS: $2.44-55.2%Miss